These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1464963

  • 1. [A fundamental study of 99mTc-ethyl cysteinate dimer (99mTc-ECD)].
    Mimura H, Ono S, Yanagimoto S, Tomomitsu T, Nishimura F, Muranaka A, Morita K, Nagai K, Otsuka N, Fukunaga M.
    Kaku Igaku; 1992 Oct; 29(10):1227-36. PubMed ID: 1464963
    [Abstract] [Full Text] [Related]

  • 2. [Usefulness of 99mTc-ECD SPECT in diseases of the central nerve system: special reference to a comparison with 123I-IMP and 99mTc-HM-PAO SPECT].
    Ono S, Yanagimoto S, Mimura H, Otsuka N, Nagai K, Morita K, Tomomitsu T, Muranaka A, Watanabe A, Ishii R.
    Kaku Igaku; 1992 Dec; 29(12):1429-40. PubMed ID: 1491488
    [Abstract] [Full Text] [Related]

  • 3. [Metabolism of 99mTc-ethyl cysteinate dimer (99mTc-ECD) in blood--mainly in vitro].
    Inoue Y, Momose T, Amo K, Ohtake T, Watanabe T, Kosaka N, Nishikawa J, Sasaki Y.
    Kaku Igaku; 1992 Aug; 29(8):955-62. PubMed ID: 1434085
    [Abstract] [Full Text] [Related]

  • 4. [Clinical usefulness of 99mTc-ECD--a multicenter phase 3 study].
    Yonekura Y, Sasaki Y, Kubo A, Tanada S, Momose T, Torizuka K.
    Kaku Igaku; 1993 Apr; 30(4):397-410. PubMed ID: 8315890
    [Abstract] [Full Text] [Related]

  • 5. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, Narayan M, Bennett A, Delaney RC, Bronen RA, Hoffer PB.
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [Abstract] [Full Text] [Related]

  • 6. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.
    Léveillé J, Demonceau G, Walovitch RC.
    J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of brain perfusion SPECT imaging using 99mTc-ECD].
    Matsuda H, Kinuya K, Higashi S, Kawasaki Y, Sumiya H, Shuke N, Hisada K, Yamashita J, Yamaguchi N.
    Kaku Igaku; 1991 Jul; 28(7):701-9. PubMed ID: 1920946
    [Abstract] [Full Text] [Related]

  • 8. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET.
    Tsuchida T, Nishizawa S, Yonekura Y, Sadato N, Iwasaki Y, Fujita T, Matoba N, Magata Y, Tamaki N, Konishi J.
    J Nucl Med; 1994 Jan; 35(1):27-31. PubMed ID: 8271056
    [Abstract] [Full Text] [Related]

  • 9. Effect of cyclodextrin complexation on the in vivo disposition of the brain imaging radiopharmaceutical 99mTechnetium ethyl cysteinate dimer (99mTc-ECD).
    Oliver DW, Dormehl IC, Louw W, Kilian E, de Beco V, Morretti JL.
    Arzneimittelforschung; 2000 Aug; 50(8):758-64. PubMed ID: 10994161
    [Abstract] [Full Text] [Related]

  • 10. Metabolism of technetium-99m-L,L-ethyl cysteinate dimer in rat and cynomolgus monkey tissue.
    Inoue Y, Momose T, Ohtake T, Nishikawa J, Sasaki Y, Waritani T, Inoue M.
    J Nucl Med; 1997 Nov; 38(11):1731-7. PubMed ID: 9374342
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe.
    Oku N, Matsumoto M, Hashikawa K, Moriwaki H, Ishida M, Seike Y, Terakawa H, Watanabe Y, Uehara T, Nishimura T.
    J Nucl Med; 1997 Jul; 38(7):1109-11. PubMed ID: 9225799
    [Abstract] [Full Text] [Related]

  • 13. Technetium-99m-ECD SPECT fails to show focal hyperemia of acute herpes encephalitis.
    Fazekas F, Roob G, Payer F, Kapeller P, Strasser-Fuchs S, Aigner RM.
    J Nucl Med; 1998 May; 39(5):790-2. PubMed ID: 9591576
    [Abstract] [Full Text] [Related]

  • 14. Quantitative comparison between 99mTc-HMPAO and 99mTc-ECD: measurement of arterial input and brain retention.
    Pupi A, Castagnoli A, De Cristofaro MT, Bacciottini L, Petti AR.
    Eur J Nucl Med; 1994 Feb; 21(2):124-30. PubMed ID: 8162935
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of 99mTc-L,L-ethyl cysteinate dimer in healthy volunteers.
    Walovitch RC, Franceschi M, Picard M, Cheesman EH, Hall KM, Makuch J, Watson MW, Zimmerman RE, Watson AD, Ganey MV.
    Neuropharmacology; 1991 Mar; 30(3):283-92. PubMed ID: 1906585
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO].
    Makino K, Masuda Y, Gotoh S.
    Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624
    [Abstract] [Full Text] [Related]

  • 17. Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects.
    Vallabhajosula S, Zimmerman RE, Picard M, Stritzke P, Mena I, Hellman RS, Tikofsky RS, Stabin MG, Morgan RA, Goldsmith SJ.
    J Nucl Med; 1989 May; 30(5):599-604. PubMed ID: 2497233
    [Abstract] [Full Text] [Related]

  • 18. [Discrepancy between 99mTc-HMPAO and 99mTc-ECD in Alzheimer's disease: does the retention mechanism depend on the disease?].
    Komatani A, Sugai Y, Watanabe N, Yamaguchi K, Kawakatsu S.
    Kaku Igaku; 1998 Oct; 35(8):715-20. PubMed ID: 9847513
    [Abstract] [Full Text] [Related]

  • 19. [Phase I clinical study of 99mTc-ECD].
    Kubo A, Nakamura K, Tsukatani Y, Sanmiya T, Shimizu S, Yokoyama K, Hashimoto S, Torizuka K.
    Kaku Igaku; 1992 Aug; 29(8):1019-27. PubMed ID: 1434082
    [Abstract] [Full Text] [Related]

  • 20. Discordance of technetium-99m-HMPAO and technetium-99m-ECD SPECT in herpes simplex encephalitis.
    Rieck H, Adelwöhrer C, Lungenschmid K, Deisenhammer E.
    J Nucl Med; 1998 Sep; 39(9):1508-10. PubMed ID: 9744332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.